Your browser doesn't support javascript.
loading
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma.
Azmi, Asfar S; Khan, Husain Yar; Muqbil, Irfana; Aboukameel, Amro; Neggers, Jasper E; Daelemans, Dirk; Mahipal, Amit; Dyson, Gregory; Kamgar, Mandana; Al-Hallak, Mohammad Najeeb; Tesfaye, Anteneh; Kim, Steve; Shidham, Vinod; M Mohammad, Ramzi; Philip, Philip A.
Afiliação
  • Azmi AS; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan. azmia@karmanos.org philipp@karmanos.org.
  • Khan HY; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Muqbil I; Department of Chemistry, University of Detroit Mercy, Detroit, Michigan.
  • Aboukameel A; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Neggers JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Daelemans D; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, Leuven, Belgium.
  • Mahipal A; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, Leuven, Belgium.
  • Dyson G; Mayo Clinic, Rochester, Minnesota.
  • Kamgar M; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Al-Hallak MN; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Tesfaye A; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Kim S; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Shidham V; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • M Mohammad R; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Philip PA; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
Clin Cancer Res ; 26(6): 1338-1348, 2020 03 15.
Article em En | MEDLINE | ID: mdl-31831564
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores Citoplasmáticos e Nucleares / Carcinoma Ductal Pancreático / Carioferinas Tipo de estudo: Clinical_trials Limite: Animals / Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores Citoplasmáticos e Nucleares / Carcinoma Ductal Pancreático / Carioferinas Tipo de estudo: Clinical_trials Limite: Animals / Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article